Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA
The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 2022-01, Vol.209, p.8-15 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15 |
---|---|
container_issue | |
container_start_page | 8 |
container_title | Thrombosis research |
container_volume | 209 |
creator | Tóth, Erzsébet Beinrohr, László Gubucz, István Szabó, László Tenekedjiev, Kiril Nikolova, Natalia Nagy, Anikó I. Hidi, László Sótonyi, Péter Szikora, István Merkely, Béla Kolev, Krasimir |
description | The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients.
Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured.
Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels.
The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis.
•Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels. |
doi_str_mv | 10.1016/j.thromres.2021.11.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2604833104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384821005193</els_id><sourcerecordid>2604833104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhL1Q-ckmwY6-T3KgKBaQKLiCO1sQeq16ceLGdLf0z_Fa8bMuV01y-997MPEIuOGs54-rNri23Kc4Jc9uxjrect4zzJ2TDh35sOtl3T8mGMTk2YpDDGXmR844x3vNx-5ycCTlIyaTakN_Xfkp-oSXSQ1zodx8CTgkWSx2YEhNNUHyklYBUMHkI9G_w5KnPFHKOxkNBS-98uaX7AHkGGvCAIdPoqs4FmGeoTvd08nGG9ANTFdaAEE11g2ldLCwGjzj-KgkMhrAGSPTd58uX5JmDkPHVwzwn367ff7362Nx8-fDp6vKmMUJw3sBgQAydcp2xQ-eQWaU4V1I6I-y4Ndbh1KNFoZQ1wikupmm7HTvjLOvHcRDn5PXJd5_izxVz0bPPx0Vgwbhm3SkmhxrFZEXVCTUp5pzQ6X3y9a57zZk-dqN3-rEbfexGc65rN1V48ZCxTjPaf7LHMirw9gTU5-HBY9LZeKyvsT6hKdpG_7-MP0Typ8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604833104</pqid></control><display><type>article</type><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</creator><creatorcontrib>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</creatorcontrib><description>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients.
Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured.
Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels.
The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis.
•Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2021.11.011</identifier><identifier>PMID: 34844046</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Biomarkers ; Brain Ischemia ; DNA ; Fibrin ; Humans ; Male ; Myocardial infarction ; Neutrophil extracellular traps ; Peripheral artery disease ; Stroke ; Thrombosis ; von Willebrand Factor</subject><ispartof>Thrombosis research, 2022-01, Vol.209, p.8-15</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</citedby><cites>FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0049384821005193$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34844046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tóth, Erzsébet</creatorcontrib><creatorcontrib>Beinrohr, László</creatorcontrib><creatorcontrib>Gubucz, István</creatorcontrib><creatorcontrib>Szabó, László</creatorcontrib><creatorcontrib>Tenekedjiev, Kiril</creatorcontrib><creatorcontrib>Nikolova, Natalia</creatorcontrib><creatorcontrib>Nagy, Anikó I.</creatorcontrib><creatorcontrib>Hidi, László</creatorcontrib><creatorcontrib>Sótonyi, Péter</creatorcontrib><creatorcontrib>Szikora, István</creatorcontrib><creatorcontrib>Merkely, Béla</creatorcontrib><creatorcontrib>Kolev, Krasimir</creatorcontrib><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients.
Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured.
Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels.
The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis.
•Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</description><subject>Biomarkers</subject><subject>Brain Ischemia</subject><subject>DNA</subject><subject>Fibrin</subject><subject>Humans</subject><subject>Male</subject><subject>Myocardial infarction</subject><subject>Neutrophil extracellular traps</subject><subject>Peripheral artery disease</subject><subject>Stroke</subject><subject>Thrombosis</subject><subject>von Willebrand Factor</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EokvhL1Q-ckmwY6-T3KgKBaQKLiCO1sQeq16ceLGdLf0z_Fa8bMuV01y-997MPEIuOGs54-rNri23Kc4Jc9uxjrect4zzJ2TDh35sOtl3T8mGMTk2YpDDGXmR844x3vNx-5ycCTlIyaTakN_Xfkp-oSXSQ1zodx8CTgkWSx2YEhNNUHyklYBUMHkI9G_w5KnPFHKOxkNBS-98uaX7AHkGGvCAIdPoqs4FmGeoTvd08nGG9ANTFdaAEE11g2ldLCwGjzj-KgkMhrAGSPTd58uX5JmDkPHVwzwn367ff7362Nx8-fDp6vKmMUJw3sBgQAydcp2xQ-eQWaU4V1I6I-y4Ndbh1KNFoZQ1wikupmm7HTvjLOvHcRDn5PXJd5_izxVz0bPPx0Vgwbhm3SkmhxrFZEXVCTUp5pzQ6X3y9a57zZk-dqN3-rEbfexGc65rN1V48ZCxTjPaf7LHMirw9gTU5-HBY9LZeKyvsT6hKdpG_7-MP0Typ8c</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Tóth, Erzsébet</creator><creator>Beinrohr, László</creator><creator>Gubucz, István</creator><creator>Szabó, László</creator><creator>Tenekedjiev, Kiril</creator><creator>Nikolova, Natalia</creator><creator>Nagy, Anikó I.</creator><creator>Hidi, László</creator><creator>Sótonyi, Péter</creator><creator>Szikora, István</creator><creator>Merkely, Béla</creator><creator>Kolev, Krasimir</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202201</creationdate><title>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</title><author>Tóth, Erzsébet ; Beinrohr, László ; Gubucz, István ; Szabó, László ; Tenekedjiev, Kiril ; Nikolova, Natalia ; Nagy, Anikó I. ; Hidi, László ; Sótonyi, Péter ; Szikora, István ; Merkely, Béla ; Kolev, Krasimir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3311-a8ca3826f2cd82fe0d6611644fc3d95cdfeb7ede366dc3f613bb5592cfd079983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomarkers</topic><topic>Brain Ischemia</topic><topic>DNA</topic><topic>Fibrin</topic><topic>Humans</topic><topic>Male</topic><topic>Myocardial infarction</topic><topic>Neutrophil extracellular traps</topic><topic>Peripheral artery disease</topic><topic>Stroke</topic><topic>Thrombosis</topic><topic>von Willebrand Factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tóth, Erzsébet</creatorcontrib><creatorcontrib>Beinrohr, László</creatorcontrib><creatorcontrib>Gubucz, István</creatorcontrib><creatorcontrib>Szabó, László</creatorcontrib><creatorcontrib>Tenekedjiev, Kiril</creatorcontrib><creatorcontrib>Nikolova, Natalia</creatorcontrib><creatorcontrib>Nagy, Anikó I.</creatorcontrib><creatorcontrib>Hidi, László</creatorcontrib><creatorcontrib>Sótonyi, Péter</creatorcontrib><creatorcontrib>Szikora, István</creatorcontrib><creatorcontrib>Merkely, Béla</creatorcontrib><creatorcontrib>Kolev, Krasimir</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tóth, Erzsébet</au><au>Beinrohr, László</au><au>Gubucz, István</au><au>Szabó, László</au><au>Tenekedjiev, Kiril</au><au>Nikolova, Natalia</au><au>Nagy, Anikó I.</au><au>Hidi, László</au><au>Sótonyi, Péter</au><au>Szikora, István</au><au>Merkely, Béla</au><au>Kolev, Krasimir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2022-01</date><risdate>2022</risdate><volume>209</volume><spage>8</spage><epage>15</epage><pages>8-15</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>The composition of thrombi determines their structure, mechanical stability, susceptibility to lysis, and consequently, the clinical outcome in coronary artery disease (CAD), acute ischemic stroke (AIS), and peripheral artery disease (PAD). Fibrin forms the primary matrix of thrombi intertwined with DNA, derived from neutrophil extracellular traps (NETs), and von Willebrand factor (VWF) bridging DNA and platelets. Here we examined the relative content of fibrin, DNA and VWF in thrombi and analyzed their interrelations and quantitative associations with systemic biomarkers of inflammation and clinical characteristics of the patients.
Thrombi extracted from AIS (n = 17), CAD (n = 18) or PAD (n = 19) patients were processed for scanning electron microscopy, (immune)stained for fibrin, VWF and extracellular DNA. Fibrin fiber diameter, cellular components, fibrin/DNA and fibrin/VWF ratios were measured.
Patients' age presented as a strong explanatory factor for a linear decline trend of the VWF content relative to fibrin in thrombi from CAD (adjusted-R2 = 0.43) and male AIS (adjusted-R2 = 0.66) patients. In a subgroup of CAD and PAD patients with dyslipidemia and high (above 80%) prevalence of atherothrombosis a significant correlation was observed between the VWF and DNA content in thrombi (adjusted-R2 = 0.40), whereas a 3.7-fold lower linear regression coefficient was seen in AIS patients, in whom the fraction of thrombi of atherosclerotic origin was 57%. Independently of anatomical location, in patients with atherosclerosis the VWF in thrombi correlated with the plasma C-reactive protein levels.
The observed interrelations between thrombus constituents and systemic inflammatory biomarkers suggest an intricate interplay along the VWF/NET/fibrin axis in arterial thrombosis.
•Fibrin, von Willebrand factor (VWF) and NETs form an intertwined matrix in thrombi.•The positive correlation of VWF and DNA in thrombi is reinforced by atherosclerosis.•At higher DNA content the thrombi of smokers are VWF-richer and fibrin-poorer with thinner fibrin fibers.•The fibrin/VWF ratio in thrombi increases with age.•VWF in thrombi with atherosclerotic etiology correlates positively with plasma CRP-levels.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>34844046</pmid><doi>10.1016/j.thromres.2021.11.011</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 2022-01, Vol.209, p.8-15 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_2604833104 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biomarkers Brain Ischemia DNA Fibrin Humans Male Myocardial infarction Neutrophil extracellular traps Peripheral artery disease Stroke Thrombosis von Willebrand Factor |
title | Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A31%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibrin%20to%20von%20Willebrand%20factor%20ratio%20in%20arterial%20thrombi%20is%20associated%20with%20plasma%20levels%20of%20inflammatory%20biomarkers%20and%20local%20abundance%20of%20extracellular%20DNA&rft.jtitle=Thrombosis%20research&rft.au=T%C3%B3th,%20Erzs%C3%A9bet&rft.date=2022-01&rft.volume=209&rft.spage=8&rft.epage=15&rft.pages=8-15&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2021.11.011&rft_dat=%3Cproquest_cross%3E2604833104%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604833104&rft_id=info:pmid/34844046&rft_els_id=S0049384821005193&rfr_iscdi=true |